Clinical Trial Update: Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) [Phase 3]

View source ↗

Summary

Phase 3 safety and tolerability trial of ezetimibe plus statin in patients with homozygous familial hypercholesterolemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Ezetimibe (SCH 058235/MK-0653) (ezetimibe)
• SIMVASTATIN (SIMVASTATIN)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED